Cell-Derived Vesicles for mRNA Delivery

The clinical translation of messenger mRNA (mRNA)-based therapeutics requires safe and effective delivery systems. Although considerable progress has been made on the development of mRNA delivery systems, many challenges, such as the dose-limiting toxicity and specific delivery to extrahepatic tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenghua, Liu, Zhen, Wu, Jiacai, Li, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787719/
https://www.ncbi.nlm.nih.gov/pubmed/36559192
http://dx.doi.org/10.3390/pharmaceutics14122699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787719/
https://www.ncbi.nlm.nih.gov/pubmed/36559192
http://dx.doi.org/10.3390/pharmaceutics14122699

Ejemplares similares